Related Experiment Videos
Ongoing and planned studies of enhanced external counterpulsation
1Department of Medicine, University of Florida College of Medicine, Gainesville, Florida 32610-0277, USA. conticr@medicine.ufl.edu
Clinical Cardiology
|December 20, 2002
Summary
Enhanced external counterpulsation (EECP) is being studied for coronary artery disease and heart failure. Emerging research explores its potential for blood glucose control in diabetic patients with angina.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Metabolic Disorders
Background:
- Continued clinical interest in enhanced external counterpulsation (EECP) is evident through ongoing trials.
- Current applications focus on treating symptomatic coronary artery disease.
- Exploratory studies aim to elucidate the mechanisms of action for EECP.
Purpose of the Study:
- To support current indications of EECP in coronary artery disease.
- To investigate the potential of EECP in managing blood glucose for patients with angina and diabetes mellitus.
- To explore new indications for EECP, specifically in congestive heart failure.
Main Methods:
- Ongoing clinical trials supporting established EECP indications.
- Planned and ongoing exploratory studies examining EECP's mechanism of action.
- Two clinical trials, including the PEECH trial, investigating EECP for congestive heart failure.
Main Results:
- EECP is a subject of significant ongoing clinical research.
- Research is exploring EECP's efficacy beyond coronary artery disease.
- New trials are evaluating EECP for congestive heart failure patients.
Conclusions:
- EECP remains a focus of active clinical investigation.
- Potential new applications for EECP include blood glucose management and heart failure treatment.
- Further research will clarify EECP's mechanisms and expand its therapeutic role.